Nguyen, Athena N.
Plotkin, Alec L.
Odumade, Oludare A.
De Armas, Lesley
Pahwa, Savita
Morrocchi, Elena
Cotugno, Nicola
Rossi, Paolo
Foster, Caroline
Domínguez-Rodríguez, Sara
Tagarro, Alfredo
Syphurs, Caitlin
Diray-Arce, Joann
Fatou, Benoit
Ozonoff, Al
Levy, Ofer
Palma, Paolo
Smolen, Kinga K. http://orcid.org/0000-0001-8650-3693
Giaquinto, Carlo
Faggion, Silvia
Pena, Daniel Gomez
Rossi, Inger Lindfors
James, William
Nardone, Alessandra
D’Ambrosio, Federica
Zangari, Paola
Paganin, Carla
Nastouli, Eleni
Spyer, Moira
Marcelin, Anne-Genevieve
Calvez, Vincent
Rojo, Pablo
Munoz, Maria Angeles
De Rossi, Anita
Cotton, Mark
Klein, Nigel
Persaud, Deborah
De Boer, Rob J.
Schroeter, Juliane
Ceci, Adriana
Giannuzzi, Viviana
Luzuriaga, Kathrine
Kuhn, Louise
Yates, Andrew
Violari, Avy
Otwombe, Kennedy
Vaz, Paula
Lain, Maria Grazia
López-Varela, Elisa
Nhamposssa, Tacilta
Lopez, Elisa
Naniche, Denise
Goulder, Philip
Lichterfeld, Mathias
Peay, Holly
Sylla, Pr Mariam
Maiga, Almoustapha
Puthanakit, Thanyawee
Kityo, Cissy
,
Article History
Received: 17 November 2022
Revised: 14 April 2023
Accepted: 2 May 2023
First Online: 13 June 2023
Competing interests
: O.L. is a named inventor on patents relating to vaccine adjuvants and human in vitro systems to model vaccine action. O.L. reports a sponsored research agreement from GlaxoSmithKline (GSK) to evaluate vaccine adjuvants in vitro.